Literature DB >> 12066105

Assessing the risk of multiple gestation in gonadotropin intrauterine insemination cycles.

Paul F Kaplan1, Misha Patel, Douglas J Austin, Richard Freund.   

Abstract

OBJECTIVE: The purpose of this study was to analyze factors for their ability to predict multiple gestation in women who undergo controlled ovarian hyperstimulation with gonadotropins (follicle-stimulating hormone/human menopausal gonadotropin) and intrauterine insemination. STUDY
DESIGN: This was a retrospective analysis of the clinical and laboratory variables that are associated with multiple gestation. Data for 6 variables in 678 cycles of gonadotropin/intrauterine insemination between 1990 and 1999 were analyzed with survival analysis, Cox regression analysis, and multiple logistic regression.
RESULTS: There were 99 clinical pregnancies among 678 cycles (14.6% per cycle) in 306 women. Of the 14 women with multiple gestations (14.1% of pregnancies), 11 women had twins, 2 women had triplets, and 1 woman had quadruplets. Age, days of gonadotropin treatment, total dose of gonadotropin, and number of follicles that were >or=15 mm at the time of human chorionic gonadotropin administration were statistically significant predictors of multiple gestation in >or=1 of the statistical models.
CONCLUSION: The risk of multiple gestation with controlled ovarian hyperstimulation/intrauterine insemination in this study was relatively low. In addition to age, several controllable variables that are associated with multiple gestation were identified.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12066105     DOI: 10.1067/mob.2002.123739

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  A profile of Bruno Lunenfeld, MD, FRCOG, FACOG (hon).

Authors:  Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2018-09       Impact factor: 8.661

Review 2.  Optimal management of subfertility in polycystic ovary syndrome.

Authors:  Joshua J Berger; G Wright Bates
Journal:  Int J Womens Health       Date:  2014-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.